{"rows":[{"id":4075,"title":"A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations","authors":"Ana Deutsch, Luis E. Contreras, Sarah Kratina, Leah M. Mayo","journal":"Therapeutic Advances in Psychopharmacology","publication_date":"2026-02-28","publication_year":2026,"doi":"10.1177/20451253261433836","pubmed_id":"41918771","openalex_id":"https://openalex.org/W7141801946","source_url":"https://doi.org/10.1177/20451253261433836","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,End-of-Life Distress,Chronic Pain,Mechanism of Action,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Toxicity","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:36","last_checked":"2026-07-04 06:34:36","bibtex":null,"source_record_id":"PMID:41918771","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1177/20451253261433836","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:41918771","source_url":"https://doi.org/10.1177/20451253261433836","doi":"10.1177/20451253261433836","pmid":"41918771","publication_date":"2026-02-28","importer_version":"2.1.3","text_redistributed":false}}],"total":1,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Therapeutic Advances in Psychopharmacology","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}